Biohaven
NYSE: BHVN3 known investors
Biohaven is a biopharmaceutical company developing treatments in immunology, obesity, neuroscience, and oncology, with approved migraine therapies and a pipeline of early-to-late-stage drug development programs.
3 known investors
Biohaven is a biopharmaceutical company developing treatments in immunology, obesity, neuroscience, and oncology, with approved migraine therapies and a pipeline of early-to-late-stage drug development programs.